Importantly, we found that local administration of the NK-1R antagonist, aprepitant, significantly attenuated infection-associated decreases in bone tissue integrity and disorder compared to vehicle treated (untreated) infected animals (Fig. 1A-B). The gene discussed is TACR1; the disease is infection.